Alpha-adrenoreceptor agonistic 2-[(2-cyclopropyl-5-methyl- or 2-

Details Alpha-adrenoreceptor agonistic 2-[(2-cyclopropyl-5-methyl- or 2- Alpha-adrenoreceptor agonistic 2-[(2-cyclopropyl-5-methyl- or 2-

1985-07-03

1987-05-05

Ford, John M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

548353, A61K 31415, C07D23322

Patent

active

046633405

ABSTRACT:
The present invention relates to imidazolines of general formula (I) ##STR1## and the addition salts formed therefrom with the pharmaceutically acceptable mineral or organic acids, possibly having their own specific pharmacological properties.
The invention further relates to the preparation of these products, to their use as new medicines and to the medicinal compositions containing them.

REFERENCES:
patent: 2149473 (1939-03-01), Sonn
patent: 2915431 (1959-12-01), Carron et al.
patent: 3449355 (1969-06-01), White
Dharmsathaphorn et al., Gastroenterology, 86, pp. 120-128 (1984).
Chemical Abstracts, vol. 100, No. 13, 96148m, 1984.

Affiliated with

Also associated with

Rating

Alpha-adrenoreceptor agonistic 2-[(2-cyclopropyl-5-methyl- or 2- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alpha-adrenoreceptor agonistic 2-[(2-cyclopropyl-5-methyl- or 2-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-adrenoreceptor agonistic 2-[(2-cyclopropyl-5-methyl- or 2- will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2399529